J2H Biotech is a small molecule drug development company targeting incurable diseases. We utilize our platform technologies
OPTIFLEX and PROTACTICS to cover various therapeutic areas including metabolism, oncology, and CNS. We also provide CDMO services
with our facilities that comply with the GMP regulations to bring us a step closer to becoming a total healthcare solution provider.
-
- Smart & Fast
New drug development
company with
Niche busters strategy
- We focus on finding solutions to meet current medical unmet needs with our Niche busters development strategy and platform technologies.
To become a solution provider, we are committed to developing better medications to drive ground-breaking innovation for patients.
-
- Open Innovation strategy
with global R&D Network
- J2H Biotech is committed to building sustainable relationships with new drug development companies worldwide.
The African proverb says, “If you want to go fast, go alone. If you want to go far, go together.” We believe new drug development is a long-distance race rather than a short one. We strive to pursue success by focusing on our capabilities with continuous collaboration with partners.
Eng
